Atai Life Sciences N.V. (ETR:9VC)
Germany · Delayed Price · Currency is EUR 3.267
-0.247 (-7.03%)
Aug 14, 2025, 4:00 PM EDT
Atai Life Sciences Market Cap
Atai Life Sciences has a market cap or net worth of €702.94 million as of August 15, 2025. Its market cap has increased by 193.19% in one year.
Market Cap
702.94M
Enterprise Value
631.63M
Revenue
1.97M
Ranking
n/a
PE Ratio
n/a
Stock Price
€3.27
Market Cap Chart
Since June 18, 2021, Atai Life Sciences's market cap has decreased from 2.50B to 702.94M, a decrease of -71.92%. That is a compound annual growth rate of -26.30%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 15, 2025 | 702.94M | 226.09% |
| Dec 31, 2024 | 215.57M | 1.79% |
| Dec 29, 2023 | 211.77M | -48.71% |
| Dec 30, 2022 | 412.86M | -61.61% |
| Dec 31, 2021 | 1.08B | -57.03% |
| Jun 18, 2021 | 2.50B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Siemens Healthineers AG | 51.79B |
| Merck KGaA | 48.28B |
| Bayer Aktiengesellschaft | 26.33B |
| Fresenius SE & Co. KGaA | 24.87B |
| Sartorius Aktiengesellschaft | 12.45B |
| Fresenius Medical Care AG | 12.13B |
| Fielmann Group AG | 4.65B |
| Carl Zeiss Meditec AG | 3.77B |